Resistance, heteroresistance, and fitness costs drive colistin treatment failure during Acinetobacter baumannii pneumonia. (pnas.org)

Authors: Hernandez-Bird J … Isberg RR Journal: PNAS Published: 2026-01-06 DOI: https://doi.org/10.1073/pnas.2515303123